Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 17, 2003Annals of Pharmacotherapy

Linezolid Resistance since 2001: SENTRY Antimicrobial Surveillance Program

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAlan H. MutnickTufts UniversityRJRonald N. JonesNorthwestern University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mutnick et al. (2003) studied this question.

synapsesocial.com/papers/6a8bbfdcb676b7d1a2fb7829https://doi.org/10.1345/aph.1c437
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Gene Dosage and Linezolid Resistance in Enterococcus faecium and Enterococcus faecalis2002 · 267 citations
  2. 2Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–19992001 · 1,366 citations
  3. 3Hospital Admissions Resulting from Preventable Adverse Drug Reactions2002 · 580 citations
  4. 4Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme1999 · 119 citations